Titan Pharmaceuticals Inc (TTNP)
7.09
+0.12
(+1.72%)
USD |
NASDAQ |
Apr 26, 16:00
7.09
0.00 (0.00%)
After-Hours: 20:00
Titan Pharmaceuticals Max Drawdown (5Y): 99.91% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.91% |
| February 29, 2024 | 99.91% |
| January 31, 2024 | 99.91% |
| December 31, 2023 | 99.91% |
| November 30, 2023 | 99.91% |
| October 31, 2023 | 99.91% |
| September 30, 2023 | 99.91% |
| August 31, 2023 | 99.91% |
| July 31, 2023 | 99.91% |
| June 30, 2023 | 99.91% |
| May 31, 2023 | 99.91% |
| April 30, 2023 | 99.91% |
| March 31, 2023 | 99.91% |
| February 28, 2023 | 99.91% |
| January 31, 2023 | 99.91% |
| December 31, 2022 | 99.91% |
| November 30, 2022 | 99.91% |
| October 31, 2022 | 99.91% |
| September 30, 2022 | 99.91% |
| August 31, 2022 | 99.91% |
| July 31, 2022 | 99.91% |
| June 30, 2022 | 99.91% |
| May 31, 2022 | 99.91% |
| April 30, 2022 | 99.86% |
| March 31, 2022 | 99.86% |
| Date | Value |
|---|---|
| February 28, 2022 | 99.86% |
| January 31, 2022 | 99.86% |
| December 31, 2021 | 99.86% |
| November 30, 2021 | 99.83% |
| October 31, 2021 | 99.81% |
| September 30, 2021 | 99.80% |
| August 31, 2021 | 99.80% |
| July 31, 2021 | 99.80% |
| June 30, 2021 | 99.80% |
| May 31, 2021 | 99.80% |
| April 30, 2021 | 99.79% |
| March 31, 2021 | 99.79% |
| February 28, 2021 | 99.78% |
| January 31, 2021 | 99.78% |
| December 31, 2020 | 99.78% |
| November 30, 2020 | 99.78% |
| October 31, 2020 | 99.74% |
| September 30, 2020 | 99.67% |
| August 31, 2020 | 99.67% |
| July 31, 2020 | 99.67% |
| June 30, 2020 | 99.67% |
| May 31, 2020 | 99.67% |
| April 30, 2020 | 99.67% |
| March 31, 2020 | 99.67% |
| February 29, 2020 | 99.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.40%
Minimum
Apr 2019
99.91%
Maximum
May 2022
99.64%
Average
99.80%
Median
Max Drawdown (5Y) Benchmarks
| Outset Medical Inc | -- |
| Allurion Technologies Inc | -- |
| AIM ImmunoTech Inc | 99.76% |
| Protalix BioTherapeutics Inc | 94.35% |
| Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -82.62 |
| Beta (5Y) | 1.331 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.1% |
| Historical Sharpe Ratio (5Y) | -0.6519 |
| Historical Sortino (5Y) | -1.380 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.76% |